Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes
2016 · The Breast · 46 citations
https://doi.org/10.1016/j.breast.2016.08.003
T
Tomoko Higuchi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
1.4K
Citations
21
h-index
31
i10-index
Tomoko Higuchi is an academic researcher from Hyogo Medical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Breast Cancer Treatment Studies & Medical Imaging Techniques and Applications. The author has an h-index of 21, co-authored 68 publications.
Papers by this author
worksPrognostic value of FDG-PET and DWI in breast cancer
2017 · Annals of Nuclear Medicine · 46 citations
https://doi.org/10.1007/s12149-017-1217-9
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine
2019 · Scientific Reports · 33 citations
https://doi.org/10.1038/s41598-018-37633-0
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers
2019 · Breast Cancer · 33 citations
https://doi.org/10.1007/s12282-019-00977-0
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer
2024 · International Journal of Clinical Oncology · 6 citations
https://doi.org/10.1007/s10147-024-02625-w
Clinical implications of peripheral blood biomarkers in patients with advanced breast cancer treated with trastuzumab emtansine and trastuzumab deruxtecan
2025 · International Journal of Clinical Oncology · 2 citations
https://doi.org/10.1007/s10147-025-02768-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat